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Moderate/severe diffuse infiltration showed a negative prognostic impact on progression-free (p<0.001) and overall survival (p=0.003) compared to salt and pepper/minimal diffuse infiltration. A number of >25 focal lesions on whole-body or >7
on axial magnetic resonance imaging, were associated with an adverse prognosis (progression-free survival: p=0.001/0.003 and overall survival: p=0.04/0.02).
A magnetic resonance imaging-based prognostic scoring system, combining grouped diffuse and focal infiltration patterns, was formulated and is applicable to whole-body as well as axial magnetic resonance imaging. The score identified high-risk patients with a median progression-free and overall survival of 23.4 and 55.9 months, respectively (whole-body-based). Multivariate analyses demonstrated that the magnetic resonance imaging-based prognostic score stage III (high-risk) and adverse cytogenetics remain as independent prognostic factors for both, progression-free and overall survival (whole-body-based, progression-free survival:
hazard ratio=3.65, p<0.001; overall survival: hazard ratio=5.19, p=0.005).
In conclusion, we suggest a magnetic resonance imaging-based prognostic scoring system which is a robust easy to assess and interpret parameter summarizing significant magnetic resonance imaging findings in transplant-eligible multiple myeloma patients.
Introduction
Although the vast majority of patients with multiple myeloma (MM) remains incurable, their median survival has improved markedly thanks to the introduction of high dose chemotherapy in combination with novel agents such as proteasome inhibitors and immunomodulatory drugs 1, 2 . Currently accepted prognostic scores predicting progression-free (PFS) and overall survival (OS) of new-diagnosed MM patients are based on laboratory values, namely the International Staging System (ISS) 3 , cytogenetic analyses 4, 5 or combinations of both 6, 7 . None of these include imaging criteria so far. Cytogenetic aberrations will reflect the molecular biology of the malignant cells, and laboratory results mainly their secretory activity and indirectly the tumor mass. Imaging findings, especially when using dedicated whole body protocols in magnetic resonance imaging (wbMRI) and positron emission computed tomography (PET-CT), may help to estimate the total burden of tumor cells in the bone marrow. Further, MRI can depict the spatial distribution of the tumor cells, which might reflect some of their biological as well as disease features [8] [9] [10] [11] . MRI in particular is progressively being used in clinical routine in accordance with the current diagnostic guidelines of the International Myeloma Working Group (IMWG) [11] [12] [13] . Furthermore, MRI findings have recently been incorporated in the revised IMWG criteria to define symptomatic MM, which makes it necessary to perform an MRI at baseline for patients who do not fulfill the classical CRAB criteria 14 . Different bone marrow infiltration patterns, such as focal lesions (FL), diffuse infiltration (DI), including a so-called salt and pepper pattern (S&P), can be detected 12, 15 .
In symptomatic MM, the presence of more than 7 FL in an axial MRI (axMRI) is associated with a shorter OS 9 . In asymptomatic stages of monoclonal plasma cell diseases, more than one focal lesion as well as a progression over time of a focal or 6 diffuse infiltration have been shown to be associated with a higher risk of progression into symptomatic disease [16] [17] [18] . Diffuse infiltration patterns are associated with highrisk cytogenetics and with a poor prognosis 8, 10, 19 .
Extracting the significant information delivered by MRI studies is demanding both for the radiologist as well as the hematologist. However, a prognostic score which combines different informations delivered by MRI might help to summarize the available findings in a systemic fashion and make them interpretable and comparable for the treating physician. Therefore, the present study aimed at analyzing the different MRI patterns to develop and suggest an MRI-based prognostic scoring system (MPSS) for transplant-eligible MM patients.
Methods

Subjects
We retrospectively assessed the wbMRI of 161 previously untreated transplant- Figure 1A+B ). Grouping these patterns into S&P/minimal and moderate/severe diffuse infiltration also revealed significant differences for PFS and OS, respectively (PFS: p<0.001 and OS: p=0.003, Figure 1C+D ).
The analysis of the MRI FL revealed that a higher number of FL is associated with a continuously increasing risk of shortened PFS and OS (Supplemental Figure 2A+B ).
There was no unique FL cut-off to distinguish patients at lower or higher risk.
Therefore, we defined a distribution-based cut-off of FL numbers at the 3rd quartile (Q3, approximately 25% of patients with the highest number of FL) to define patients at a high risk. In this cohort, the 3rd quartile using wbMRI was 25 FL and, when only counting axial FL 7 FL. PFS as well as OS were significantly different when these cut-offs were applied (PFS: wbFL p=0.001, axFL p=0.004 and OS: wbFL p=0.04, axFL p=0.02, respectively, Figure 2A -D). There were no major changes in the composition of the MPSS when using either the wbFL or axFL cut-offs (Supplemental Table 3 ).
The classification according to the MPSS and the 3-year PFS and 5-year OS rates (%) when using either wbMRI or axMRI are shown in The wb-as well as the ax-MPSS were able to reliably distinguish PFS and OS for the three different stages. With the exception of the discrimination between stage II and III when using the wb-MPSS (borderline significance, p=0.05, Figure 3B ), all pairwise multiplicity-adjusted log-rank tests between the defined wb-and ax-MPSS, were significant ( Figure 3A-D) .
The wb-and ax-MPSS were then incorporated into a multivariate Cox PH model to evaluate their prognostic impact on PFS and OS (Table 3) . In this analysis, the MPSS stages II and III were independent highly significant prognostic parameters for . However, to date the significance of the combination of the key information acquired from MRI, i.e. number of focal lesions and degree of diffuse infiltration, has not been evaluated.
In the present retrospective study we could confirm that both, DI and FL in MRI, have an important impact on PFS and OS. We combined these MRI patterns for the first time to create an MRI-based prognostic scoring system (MPSS) for new-diagnosed transplant-eligible MM-patients. MPSS is able to identify patients with a poor PFS and OS and was proven independent as a prognostic risk indicator in our subsequent multivariate analyses.
The DI and FL found in MRI have been shown to correlate with different growth patterns in histology 26 and therefore appear to be of pathophysiological significance.
Several studies established the adverse prognostic significance of DI in MRI 8, 10, 19 . It is difficult for the reader, however, to differentiate reliably between a moderate and a severe DI, since there is no objective measure for the signal intensity of the bone marrow. Furthermore, a delayed fatty conversion of normal bone marrow in middleaged patients as well as reactive changes are possible sources of error 27 . It must also be concerned that FL may be difficult to delineate if they lie within a diffusely infiltrated bone marrow. While our study could confirm previous data on the prognostic significance of the DI overall, we also found a favorable prognostic implication of a micro-nodular/S&P DI, which has not yet been described in a large cohort ( Figure 1 ). Indeed, we saw that this distinct pattern has the same prognostic significance as a minimal infiltration appearing as "normal" image in MRI.
Furthermore, we were able to demonstrate that moderate and severe DI do not significantly differ regarding their prognostic value 22 . We therefore think that a differentiation between homogeneous DI (i.e. moderate and severe) and minimal/normal together with S&P may be sufficient.
Accordingly, the number of MRI FL has a notoriously adverse impact on PFS and OS. A study conducted by Walker et al. 9 , using axial MRI, identified a cut-off value of >7 FL as an independent adverse factor for event-free survival (EFS) and OS. Twohundred and twelve of 611 patients, approximately 36%, had >7 FL on axial MRI 9 .
A relative hazard analysis based on a Cox model revealed a continuously increasing risk for an adverse PFS and OS depending on an increased number of FL (Supplemental Figure 2 ). In addition, although the prognosis became progressively and continuously worse with the number of FL, our search for an optimal cut-point did not reveal a unique cut-off point in our cohort (data not shown). This allows the conclusion that based on the FL number, no unique cut-off between low and high-risk patients existed. Therefore, we decided to choose a distribution-based cut-off at the 3rd quartile (representing approximately 25% of all patients). This cut-off was set at >25 FL for wbMRI and >7 for axMRI in our cohort (Figure 2 ) -the latter being in line with the previous studies by Walker et al. performing axial MRI as described above 9 .
While DI is best identified in the spine or pelvis and therefore wbMRI is not mandatory to acquire this information, a comparative study of wbMRI and axMRI revealed that about 10% of patients show FL exclusively outside the axial skeleton 21 .
However, since wbMRI is not available in all institutions, we decided to calculate the cut-offs for whole-body as well as for axial MRI and provide results for both. Whether wbMRI will be required or spinal/axial MRI may be sufficient in patients with monoclonal plasma cell diseases will have to be evaluated in future studies. Notably, CT, if performed additionally, is valid for detecting both focal and diffuse disease in the appendicular skeleton, at least in the shafts of long bones.
In our multivariate analysis, FL cut-offs as well as the moderate/severe DI pattern remained significant independent prognostic factors for PFS and OS together with adverse cytogenetics (Table 1) , as previously reported 8, 9, 22 . Other known prognostic factors, such as an elevated LDH, ISS stage III and IT with novel agents, however, did often not reach statistical significance. Though a stronger impact of ISS and LDH on OS compared to PFS has been described 7, 28 and is in line with our results, this might be impeded by the sample size of our cohort. Further, previously described correlations between higher ISS stages and DI 8, 19 might weaken the effects of these factors in our multivariate analyses.
The information summarized in the MPSS can be determined rapidly in clinical routine and the MPSS can therefore be calculated without significant additional effort by the radiologist (Table 2) . Independent on the examination technique (wbMRI or axMRI), the allocation to the different stages is not affected (Supplemental Table 3) and the discrimination between the three stages works reliably ( Figure 3 (Table 3) . This underscores the importance of an additional evaluation of an MRI.
Providing information on plasma cell infiltration (DI and FL patterns) in a large volume of bone marrow, MRI complements CT whose chief strength is to detect destruction of mineralized bone 15, 29 . The current study supports the use of MRI in clinical routine in addition to CT for new-diagnosed, symptomatic MM since it shows that the MRI adds significant information on prognosis and treatment necesstiy 14 .
In comparison to other prognostic scores such as the ISS 3 , MRI provides additional clinical information, e.g. on extramedullary disease (EMD) or spinal cord compression. As previously described, MRI can be repeated after key therapeutic steps to reassess prognosis and treatment response independent of serological markers 20, 30 .
The question whether PET-CT rather than MRI should be used in monoclonal plasma cell diseases for assessment of bone marrow infiltration and extramedullary disease has not been clarified yet. MRI seems to be superior at initial staging due to its high sensitivity for both FL and DI, whereas PET-CT provides information on metabolic activity and therefore helps to assess treatment response early and more precisely 31,32 .
Two articles by Moulopoulos et al. 8, 10 demonstrated that DI MRI correlates with adverse cytogenetics, higher ISS, anemia and increased biomarkers of angiogenesis. This might partially explain the poor prognosis associated with moderate/severe DI. More than 7 FL are associated with lowered serum albumin, higher LDH, c-reactive protein and creatinine values 9 . In another study, the presence of FL was associated with a higher number of osteolytic lesions than moderate/severe or minimal DI 8 . No correlation was seen between bone marrow plasmocytosis, hemoglobin value or adverse cytogenetics 8, 9 . A further analysis of these connections might advance the understanding of the pathophysiology of different MRI patterns in MM.
Limitations of the current study are its retrospective and the single-center character.
In addition, there was no stratification of patients according to induction and/or maintenance therapies. A further validation of the score in independent cohorts is planned.
In summary, our study demonstrated that both, DI and FL MRI pattern have a significant impact on PFS and OS. Minimal and S&P DI are favorable patterns, whereas moderate/severe DI are unfavorable ones. The prognosis becomes increasingly worse with a higher number of FL without a distinct cut-off. However, an arbitrary cut-off value at the highest quartile (>25/>7 FL in wb/axMRI) allows a reliable prognostic discrimination with reasonable effort for the radiologist. The 
